TGFB1 and breast carcinoma: Interestingly, FBXO3 promotes the ubiquitylation and degradation of ΔNp63α to enhance TGF-β signaling and accelerate tumor metastasis, indicating that FBXO3 may be a potential therapeutic target for advanced breast cancer treatment [39].